PATENT CLAIM ANALYSIS

Application Number: 16060109
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["514", "004800"]

Abstract:
The invention provides compositions and methods for inhibiting protein-protein interactions with cap-binding protein 80 (CBP80). In one embodiment, the invention provides compositions comprising linear and macrocylic peptides. In one embodiment, the invention provides methods for treating cancer, heart disease, autoimmune disorders, obesity, diabetes, or chronic inflammation disorders associated with the PGC1 family of co-activators.

Claim (Index 6):
The macrocyclic peptide of  claim 1 , wherein the peptide inhibits the binding of CBP80 to a binding partner.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 94.0
- Lexical Diversity: 1.53488
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14398260', '15941030', '14800627', '14118545', '09825517']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.843696609226356
- 35 USC 102 Novelty (BERT): 0.576223211538415
- Combined Prediction Score: 0.816949269457562
- Mean Citation Score: 553.978646
- Max Citation Score: 558.4818
- Similarity Product: 340.0236227739215

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test